This report describes the case of a 57-year-old 
Introduction

Obesity-related nephropathy has recently been proposed to be a cause of renal injury (1, 2). The pathological characteristics of obesity-related nephropathy are glomerulomegaly and focal segmental glomerulosclerosis (FSGS) (1). The clinical manifestation of obesity-related FSGS differs from the classic idiopathic FSGS and it is characterized by less proteinuria and a more indolent progression (1). Although the precise mechanisms of this abnormality are currently unknown, studies have indicated that, in obese patients, renal hyperperfusion and hyperfiltration are markedly increased (3, 4). Since obesity induces single-nephron adaptations even at normal nephron capacity, nephron overwork and the risk of intraglomerular hypertension in obesity would thus be exaggerated if the total number of nephrons was already low. This hypothesis is supported by a recent study showing that obese patients are at high risk of developing proteinuria and renal impairment when a unilateral nephrectomy is performed (5). However, the notion that excess weight accelerates the progression of renal impairment associated with a low nephron number should not be restricted to surgical causes of nephron loss. Of perhaps greater clinical importance, similar additive deleterious effects of obesity would therefore be expected in individuals with chronic kidney diseases which could potentially cause a progressive nephron loss.
Case Report
The patient was a 57-year-old man airplane pilot with a medical history of a tonsillectomy at 10 me s a n g i a l a r e a a n d c e l l u l a r c r e s c e n t s we r e f o u n d i n mo r e t h a n 2 0 % o f g l o me r u l i , s h o wi n g a n i ma g e o f a c t i v e d i f f u s e p r o l i f e r a t i v e g l o me r u l o n e p h r i t i s ( A) . I n a n e l e c t r o n mi c r o s c o p e i ma g e , t h e me s a n g i u m a n d p a r a -me s a n g i u m a r e a s c o n t a i n e (Fig. 1D) T a b l e 2 . P a t h o l o g i c a l F i n d i n g s o f B i o p s i (3, 4) .
T a b l e 1 . Cl i n i c a l a n d L a b o r a t o r y F i n d i n g s a t t h e F i r s t a n d S e c o n d Ad mi s s i o n s
F i g u r e 2 . T h e c l i n i c a l c o u r s e o f 2 5 y e a r s f r o m t h e o n s e t . T h e p a t i e n t g r a d u a l l y b e c a me o b e s e a s h e g r e w o l d e r , a n d h i s b o d y we i g h t ( B W) , wh i c h wa s a r o u n d 6 0 k g a t f i r s t a d mi s s i o n , i n c r e a s e d t o mo r e t h a n 8 0 k g i n r e c e n t y e a r s . I n p a r a l l e l , t h e p a t i e n t ' s u r i n e p r o t e i n e x c r e t i o n ( UP E ) g r a d u a l l y i n c r e a s e d , a n d c o n s t a n t l y e x c e e d e d 1 . 0 g / 2 4 h o u r s a t 4 5 y e a r s o f a g e , a n d i t r e a c h e d 2 -3 g / 2 4 h o u r s a t 5 6 y e a r s o f a g e . T h e 2 4 -h o u r c r e a t i n i n e c l e a r a n c e ( Cc r ) , wh i c h wa s 1 3 0 mL / mi n a t t h e t i me o f f i r s t h o s p i t a l i z a t i o n , d e c r e a s e d t o 7 0 -8 0 mL / mi n .
F i g u r e 3 . Cl i n i c a l c o u r s e o f t h e f o l l o w-u p . Af t e r d i s c h a r g e , t h e p a t i e n t ' s b o d y we i g h t s t e a d i l y d e c r e a s e d . E l e v e n mo n t h s l a t e r , h i s b o d y we i g h t a n d a b d o mi n a l c i r c u mf e r e n c e we r e 7 3 k g ( -1 3 . 1 %) a n d 8 5 c m ( -9 . 6 %) , r e s p e c t i v e l y . I n p a r a l l e l , h i s b l o o d p r e s s u r e h a d d e c r e a s e d t o a l e v e l o f o p t i ma l c o n t r o l . T h e p l a s ma i n s u l i n c o n c e n t r a t i o n d e c r e a s e d ma r k e d l y f r o m t wo mo n t h s o n wa r d . T h e u r i n a r y p r o t e i n e x c r e t i o n l e v e l s ( UP E
The patient was treated with a specific angiotensinreceptor antagonist (Losartan) in addition to a calorierestricted diet. This might have resulted in an additive effect on reducing urinary protein excretion since recent studies suggest that the activation of the renin-angiotensin system is the major stimuli for an obesity-related increase in renal sodium reabsorption which leads to renal hyperperfusion and hyperfiltration (3, 14) . However, obesity and its related metabolic factors contribute to the development of renal injury through multiple mechanisms, some of which are independent from the activation of the renin-angiotensin system (2) (3) (4) 14) . Therefore, the mono-therapy of Losartan would not be expected to sufficiently reduce proteinuria in the present case. Furthermore, almost a complete disappearance of urinary protein excretion with a dramatic reduction in the nephron mass indicates the synergy of some as yet undetermined mechanisms between the functional changes induced by nephron loss and those induced by obesity (15) .
